Gene · 3921
NIH grants1,143
NIH grants whose papers are about the gene, through NIH's grant-paper links.
441 to 460 of 1,143
Download this page as JSON| Grant | Title | RPSA papers | Newest fiscal year |
|---|---|---|---|
| U24CA210950 | Integrated analysis of protein expression data from the Reverse Phase Protein Array (RPPA) platform | 1 | 2020 |
| U24CA210974 | Visualization hub for genomics data exploration and translational discovery | 1 | 2020 |
| U24CA210999 | Global Infrastructure for Collaborative High-throughput Cancer Genomics Analysis | 1 | 2020 |
| UG3TR002636 | Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles | 1 | 2020 |
| T32GM007223 | Predoctoral Program in Cellular and Molecular Biology | 3 | 2019 |
| P01HL029582 | Mechanisms linking inflammation, metabolism, and atherosclerosis. | 2 | 2019 |
| R01AI110985 | Regulation of Hematopoiesis by Ribosomal Protein Paralogs | 2 | 2019 |
| R01GM088278 | Extra-translational roles of aminoacyl tRNA synthetases in connection to disease | 2 | 2019 |
| R01GM122926 | A New Role for the PAX9 Protein in Ribosome Biogenesis | 2 | 2019 |
| R21AG059422 | Redox-based Targeting of Cerebrovascular Dysfunction in AD | 2 | 2019 |
| R21AI137371 | Inherited IRF9 deficiency: a novel genetic etiology of severe influenza | 2 | 2019 |
| U24CA194107 | GenePattern Notebooks for Cancer Research | 2 | 2019 |
| F31DE026946 | PAX9, ribosome biogenesis, and congenital disease | 1 | 2019 |
| K01AG049152 | RNA signatures of frontotemporal dementia and ALS due to C9ORF72 expansion | 1 | 2019 |
| K22AI136691 | The Influence of Early Integration Events on HIV Latency and Reactivation Potential | 1 | 2019 |
| P01DA028555 | NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence | 1 | 2019 |
| P01DK068055 | Pathobiology of the Enteric System | 1 | 2019 |
| P01HL028481 | Molecular Genetic Approaches in Atherosclerosis Research | 1 | 2019 |
| P01HL059407 | AAV Gene Therapy for Lipid Disorders | 1 | 2019 |
| P01HL076491 | Oxidation in Inflammation and Cardiovascular Disease | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3921/grants?page=23